Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology
Elangovan A, Shah R, Ali SM, Katz J, Cooper GS. High burden of obesity and low rates of…
Searches for “Ozempic face” surge as people look for filler-based solutions
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
Weight-loss drugs: From a trickle to a flood
It’s been varyingly called the “fat shot”, “skinny jab” or “magic pill” by politicians and celebrities who’ve put…
Prices of Ozempic vs Mounjaro vs Wegovy: How much they cost in the US, UK, India and around the world |
Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However,…
Ozempic vs Mounjaro vs Wegovy: Prices in India vs US and what the research actually shows
Ozempic, Mounjaro, Wegovy: Guide to Weight Loss Injections and Their Cost in India vs US Ozempic, Mounjaro and…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Karan Johar’s Ozempic joke: What you ought to know about weight loss drug
Ozempic 101: Is it behind Karan Johar’s weight loss? Fact sheet for health enthusiasts on benefits and risks…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Study finds surge in the use of weight loss drugs among bariatric surgery patients
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…